ArticleNeuropsychiatric disease and treatment2019

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).

John M Zajecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.